Literature DB >> 25531258

Epigenetic mechanisms of breast cancer: an update of the current knowledge.

Seher Karsli-Ceppioglu1, Aslihan Dagdemir, Gaëlle Judes, Marjolaine Ngollo, Frédérique Penault-Llorca, Amaury Pajon, Yves-Jean Bignon, Dominique Bernard-Gallon.   

Abstract

Epigenetic alterations are heritable changes in gene expression that occur without causing any change in DNA sequence. They are important key factors for cancer development and prognosis. Breast cancer is induced by the accumulation of altered gene regulation. Besides genetic mutations, epigenetics mechanisms have an important role in breast cancer tumorigenesis. Investigations related with aberrant epigenetic regulations in breast cancer focus on initiating molecular mechanisms in cancer development, identification of new biomarkers to predict breast cancer aggressiveness and the potential of epigenetic therapy. In this review, we will summarize the recent knowledge about the role of epigenetic alterations related with DNA methylation and histone modification in breast cancer. In addition, altered regulation of breast cancer specific genes and the potential of epigenetic therapy will be discussed according to epigenetic mechanisms.

Entities:  

Keywords:  BRCA1; DNA methylation; EZH2; breast cancer; epigenetic therapy; epigenetics; estrogen; histone modification

Mesh:

Substances:

Year:  2014        PMID: 25531258     DOI: 10.2217/epi.14.59

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  37 in total

1.  Association between shortage of energy supply and nuclear gene mutations leading to carcinomatous transformation.

Authors:  Jianping DU
Journal:  Mol Clin Oncol       Date:  2015-10-16

Review 2.  Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis.

Authors:  Juliana Carvalho Santos; Marcelo Lima Ribeiro
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

Review 3.  The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications.

Authors:  Pingping Guo; Wenqi Chen; Huiyu Li; Meiying Li; Lisha Li
Journal:  Pathol Oncol Res       Date:  2018-06-11       Impact factor: 3.201

Review 4.  The role of histone deacetylase 3 in breast cancer.

Authors:  Rezgar Rahbari; Yousef Rasmi; Mohammad Hassan Khadem-Ansari; Mohammad Abdi
Journal:  Med Oncol       Date:  2022-05-17       Impact factor: 3.064

Review 5.  Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Subhasree Nag; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2015-07-30       Impact factor: 12.944

6.  Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk.

Authors:  Vered Stearns; Mary Jo Fackler; Seema A Khan; Saraswati Sukumar; Sidra Hafeez; Zoila Lopez Bujanda; Robert T Chatterton; Lisa K Jacobs; Nagi F Khouri; David Ivancic; Kara Kenney; Christina Shehata; Stacie C Jeter; Judith A Wolfman; Carola M Zalles; Peng Huang
Journal:  Cancer Prev Res (Phila)       Date:  2016-06-03

7.  DNA Methylation in Human Breast Cancer Cell Lines Adapted to High Nitric Oxide.

Authors:  Berna Demircan; Burcu Yucel; James A Radosevich
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

Review 8.  A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species.

Authors:  Rebecca M Harman; Theresa M Curtis; David J Argyle; Scott A Coonrod; Gerlinde R Van de Walle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2016-03-22       Impact factor: 2.673

9.  Cnidium officinale Makino extract induces apoptosis through activation of caspase-3 and p53 in human liver cancer HepG2 cells.

Authors:  Heeok Hong; Jeong Cheol An; Joseph F de La Cruz; Seong-Gu Hwang
Journal:  Exp Ther Med       Date:  2017-08-09       Impact factor: 2.447

10.  KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer.

Authors:  Xinhua Liu; Rongfang Qiu; Min Xu; Miaomiao Meng; Siyu Zhao; Jiansong Ji; Yang Yang
Journal:  Breast Cancer Res Treat       Date:  2021-07-08       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.